Merck's Millipore Expands In US & China

BMI View: Faced with challenges within its pharmaceuticals unit, Merck KGaA has actively pursued inorganic growth across its more successful Millipore division. While the company has reiterated its emphasis on in-house research and development (R&D), we note it is increasingly looking at new acquisitions and emerging markets to drive future business.

To read the full article, please choose one of the following options: